Rani Therapeutics Holdings Inc - Look Forward to Initiating Phase 1 Study for Rt-114 in 2025 With Aim of Advancing Oral Anti-Obesity Treatment Option
Rani Therapeutics Holdings Inc.期待於2025年啓動Rt-114的第一階段研究,旨在推進口服抗肥胖治療選擇方案。
Rani Therapeutics Holdings Inc - Look Forward to Initiating Phase 1 Study for Rt-114 in 2025 With Aim of Advancing Oral Anti-Obesity Treatment Option
Rani Therapeutics Holdings Inc.期待於2025年啓動Rt-114的第一階段研究,旨在推進口服抗肥胖治療選擇方案。
譯文內容由第三人軟體翻譯。